Introduction
Acute kidney injury (AKI) is a common complication of critical illness and carries a high mortality, particularly if renal replacement therapy (RRT) is required [1] . A recent worldwide survey showed that 4% of patients admitted to the ICU receive RRT [1] . The incidence varies with the type of admitted patients. The observed mortality is often higher than the predicted mortality based on commonly used scores, if AKI is severe and acute renal failure (ARF) ensues [2] . It has long been postulated that patients die with ARF and not from ARF. In critically ill patients, ARF certainly is an indicator of the severity of disease. ARF rarely presents as an isolated organ dysfunction, but rather as a component of the multiple organ dysfunction syndrome, following a broad spectrum of diseases or interventions, such as severe sepsis, cardiogenic shock, major surgery or pancreatitis. Increasing evidence, however, suggests an independent effect of critical illness associated ARF on mortality [2] [3] [4] [5] . Most likely, both the acute uremic state and the unwanted consequences of the RRT contribute to this excess mortality.
Unfortunately, there is still no consensus on the optimal management of ARF. This is even more strongly the case for the application of RRT [6 ,7 ] . During the last decade both mode and dosing of RRT in the critically ill patient have received increasing interest, reflected by several randomized controlled trials (RCTs) and metaanalyses [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . These trials suggest that a dose of at least 35 ml/kg/h improves survival and that continuous treatments are not superior to intermittent treatments, except in patients with circulatory shock or cerebral edema. In contrast, so far only one RCT investigated whether timing of initiation of RRT ('timing') improves outcome in critically ill patients with AKI [8] . The results were inconclusive. The aims of the present contribution are to discuss renal and nonrenal criteria for timing in critically ill patients with AKI, considering the recent literature, and to discuss the emerging need of a consensus definition of AKI.
Classical criteria for timing
Classical criteria to start RRT include oligo-anuria, metabolic complications of the uremic state, fluid overload and uremic organ injury [23] . These criteria, however, are based on the strongly held beliefs of physicians and not on evidence from RCTs. In the absence of consensus, the Acute Dialysis Quality Initiative (ADQI) could not formulate recommendations for timing beyond these classical criteria [24] . In daily clinical practice, logistical or organizational aspects of a given institution (e.g. country, type of institution, type and organization of the unit, responsible specialty and costs) additionally influence timing. Prospective, multicenter studies on the epidemiology, management, and outcome of severe ARF reported up to two-fold differences in the reported values of urea, creatinine, or urine output at the initiation of RRT [6 ,25-27] .
Clinical studies on timing and patient outcome
During the last decade, one RCT on ARF, one on acute pancreatitis [8, 28] and four non-RCTs on ARF [29] [30] [31] [32] primarily investigated the effect of timing (early versus late) of RRT on mortality and recovery of renal function in critically ill patients (Table 1 ) [33] .
(1) In a two-center randomized controlled trial (n ¼ 106) including critically ill ventilated patients with vasopressor-dependent circulation and oliguric ARF (creatinine clearance less than 20 ml/min and diuresis less than 180 ml in 6 h, despite fluid resuscitation, inotropic support and high-dose diuretics) [ [32] , the application of early CVVH improved hemodynamics, gas exchange, successful weaning, and 28-day survival compared with a historical control group receiving conventional therapy. Only 75% of the patients in the conventional group received CVVH, despite overt renal failure, and the applied CVVH dose was lower (20 ml/kg/h) than in the early treatment group (mean daily dose 30-35 ml/kg/h). (5) In a single center retrospective cohort study in cardiac surgery patients [30] , hospital mortality was higher in the late CVVH group (n ¼ 28) compared with the early CVVH group (n ¼ 36) (43% versus 22%, P < 0.05). In the late group, CVVH was started for conventional reasons: urea of at least 30 mmol/l, creatinine of at least 250 mmol/l, or potassium of at least 6 mmol/l despite glucose infusion, regardless of urine output. In the early group, CVVH was started when urine output was less than 100 ml within 8 h, despite furosemide infusion. (6) In a single center retrospective study in patients with ARF following cardiac surgery [29] hospital mortality decreased after the introduction of early continuous venovenous hemodiafiltration (CVVHDF) compared with a historical control group (23.5% versus 55%, P ¼ 0.02). In the early group (n ¼ 34) CVVHDF was started for oliguria (urine output < 100 ml within 8 h), and in the late group (n ¼ 27) CVVHDF was started for conventional criteria (creatinine > 444 mmol/l).
In summary, a trend toward a better outcome with earlier timing of RRT emerges from the above studies, except for one RCT on AKI. The methodological quality of the trials favoring early timing is poor, however. Comparison among studies is hampered by the application of nonuniform definitions for timing, and by the heterogeneity of the study population and mode of RRT.
Timing and definition of acute kidney injury
The absence of agreement regarding the timing of RRT is illustrated in [13] Attending nephrologists decide when to start RRT Saudan [12] ARF, criteria not defined Bouman [8] Inclusion: creatinine clearance < 20 ml/min and oliguria < 180 ml/6 h despite fluid resuscitation, circulatory support and furosemide Early timing: <12 h of inclusion Late timing: BUN > 40 mmol/l or severe pulmonary edema ATN study [18] ARF defined as increase in serum creatinine of 2.0 mg/dl in men and 1.5 mg/dl in women, over no more than 4 days, or the presence of oliguria ( 20 ml/h) for more than 24 h despite fluid resuscitation Renal study [16] Oliguria (<100 ml/6 h) despite fluid resuscitation or potassium >6.5 mmol/l or pH <7.20 or urea >25 mmol/l or creatinine >300 mmol/l or clinically significant organ edema, in the setting of ARF IVOIRE study [17] RIFLE risk criteria Mode studies Mehta [10] ARF defined as a sustained rise in serum creatinine ! 1 mg/dl compared with baseline, or in the absence of prior values, BUN ! 40 mmol/l or creatinine ! 2 mg/dl Gasparovic [21] ARF defined as at least two of the following criteria: threefold increase in creatinine, K þ ! 6.5 mmol/l, BE ! À6 Augustine [20] Attending nephrologists decided when to start RRT Uehlinger [22] ARF defined as creatinine ! 350 mmol/l or oliguria < 20 ml/h Vinsonneau [15] ARF defined as urea ! 36 mmol/l or creatinine ! 310 mmol/l or oliguria < 320 ml/16 h Schwenger [19] ARF, criteria not defined ARF, acute renal failure; BUN, blood urea nitrogen; ATN, Acute Renal Failure Trial Network; RIFLE, risk of renal dysfunction, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease; BE, base excess.
proposed RIFLE classification is suitable for definition of AKI in the ICU and correlates with hospital mortality [36] [37] [38] [39] [40] 41 ] . Notably, all studies showed that mortality increased when RIFLE class goes up. The stage of AKI is already associated with increased mortality. Given the importance of early recognition of AKI, the Acute Kidney Injury Network (AKIN) promotes the term AKI and has recently modified the RIFLE classification. AKI is classified in three stages. Stage 1 is slightly more sensitive than risk, stages 2 and 3 correspond to injury and failure (Table 4) [42 ] . The AKI staging system offers a useful tool to describe the timing of initiation of RRT.
Timing and other organ failure
In addition to renal criteria, the decision of when to start RRT should consider the severity of other organ failure. Renal function is unlikely to recover soon if circulation remains vasopressor dependent and other organs fail as well. Under these circumstances clinicians are inclined to start RRT early. Animal studies support an early start in severe sepsis [43 ] . Early initiation is also supported by several observational studies describing a better survival than predicted when hemo(dia)filtration is started early in patients with refractory septic shock [44] [45] [46] . The catalyzing effect of ARF on severity of disease has a physiological base. Several uremic solutes have proinflammatory effects [47] . Moreover, uremic toxins in a proinflammatory milieu may undergo oxidative modification. Oxidation modifies the properties of the solutes which may thus become proinflammatory [48] . Early initiation of RRT in the most severely ill patients may prevent further clinical deterioration. Evidence for this suggestion, however, is poor.
Timing and biomarkers
The use of renal criteria as defined in the RIFLE and AKIN classification (creatinine and diuresis) remain a poor reflection of AKI. In particular, the earlier stages do not differentiate between so-called prerenal failure, a compensatory decrease in urinary output and glomerular filtration rate, and injury to the kidney. It seems reasonable to presume that early initiation of RRT in cases of renal compensation is less indicated because renal function is likely to recover after resuscitation of the circulation. If AKI is the result of cellular injury due to ischemia, reperfusion, inflammation or oxidant stress, however, early initiation of RRT may mitigate further damage. The development and introduction of various biomarkers for AKI is an exciting new area of research. The various biomarkers for AKI in blood and urine were recently reviewed [49 ,50 ] . The use of biomarkers may prove to be helpful in detecting AKI at an early stage, to differentiate renal compensation from AKI, to describe the type of AKI, to evaluate preventive strategies and to decide when to start or stop RRT [37, 51] .
Possible drawbacks
An important drawback for the early initiation of RRT is the fear that the patient is unnecessarily submitted to an extracorporeal technique. In the RCT of Bouman et al. [8] , patients were included when diuresis decreased to less than 180 ml within 6 h and measured creatinine clearance was less than 20 ml/min, which is comparable to the RIFLE risk to failure classification (AKI stage 2-3). In this study, four patients in the late group had spontaneous recovery of renal function without hemofiltration, and all survived. Two patients in the late group, however, died before the initiation of hemofiltration. The number of included patients is too small to firmly conclude whether early RRT is unnecessary or essential; however, it is important to realize that no deleterious effects were seen in the early groups. Biomarkers may contribute to sharpen the indications for RRT.
Conclusion
In the absence of large RCTs, we can make no firm recommendations for RRT timing in AKI. When initiation of RRT in AKI is considered, it is important Timing of renal replacement therapy Bouman and Oudemans-van Straaten 659 to realize that the consequences of uremic toxicity, metabolic acidosis and fluid overload are likely to be more severe in critically ill patients. Moreover, rapid recovery of renal function is unlikely when other organ failure persists. We therefore suggest considering AKI along with other organ failure when deciding to initiate RRT. An early start may be beneficial in patients with AKI, persisting shock and poorly recovering functions of other organs, although strong evidence for this clinical knowledge is still missing. For more robust recommendations, we need properly designed RCTs. For future studies, we recommend describing RRT timing according to renal and nonrenal criteria using the 'RIFLE' classification, as modified by AKIN, and quantifying the severity of other organ failure. Definitions of AKI and timing may be refined in the future by using biomarkers.
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